Mon, November 9, 2020

Graig Suvannavejh Upgraded (ARQT) to Strong Buy and Held Target at $36 on, Nov 9th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-36-on-nov-9th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Graig Suvannavejh of Goldman Sachs, Upgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Strong Buy and Held Target at $36 on, Nov 9th, 2020.

Graig has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with Graig's Rating of Hold.



This is the rating of the analyst that currently disagrees with Graig


  • Gregg Gilbert of "Truist Securities" Initiated at Strong Buy and Held Target at $38 on, Thursday, October 8th, 2020